In This Article:
Click here to join the case
LOS ANGELES, Oct. 06, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Longeveron, Inc. ("Longeveron" or "the Company") (NASDAQ : LGVN) investors that acquired securities between February 12, 2021 and August 12, 2021.
Investors are encouraged to contact attorney Lesley F. Portnoy, to determine eligibility to participate in this action, by phone 310-692-8883 or email, or click here to join the case.
It is alleged in this complaint that Longeveron made misleading and false statements to the market. Lomecel-B, Longeveron's cell-based therapy product, had not demonstrated the effectiveness in treating aging frailty, which it had touted to investors. Longeveron overstated the commercial prospects of Lomecel-B. Based on these facts, the Company's claims were false and materially misleading throughout the IPO and class period, based on these facts. Investors suffered damages when the market learned the truth about Longeveron.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims arising from corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
lesley@portnoylaw.com
310-692-8883
www.portnoylaw.com
Attorney Advertising